En Es
Categories

Industry News

Researchers Develop AI Algorithm to Predict Immunotherapy Response

By Medimaging International staff writers
12 Sep 2018

Image: Researchers have designed an AI algorithm that uses CT scan images to process medical images and extract biological and clinical information (Photo courtesy of iStock).A team of French researchers have designed an algorithm and developed it to analyze Computed Tomography (CT) scan images, establishing for the first time that artificial intelligence (AI) can process medical images to extract biological and clinical information. The researchers have created a so-called radiomic signature, which defines the level of lymphocyte infiltration of a tumor and provides a predictive score for the efficacy of immunotherapy in the patient.

In the near future, this could make it possible for physicians to use imaging to identify biological phenomena in a tumor located anywhere in the body without performing a biopsy.

Currently, there are no markers, which can accurately identify patients who will respond to anti-PD-1/PD-L1 immunotherapy in a situation where only 15 to 30% of patients do respond to such treatment. The more immunologically richer the tumor environment (presence of lymphocytes), the higher is the chances of immunotherapy being effective. Hence, the researchers tried to characterize this environment using imaging and correlate this with the patients’ clinical response. In their study, the radiomic signature was captured, developed and validated genomically, histologically and clinically in 500 patients with solid tumors (all sites) from four independent cohorts.

The researchers first used a machine learning-based approach to teach the algorithm how to use relevant information extracted from CT scans of patients participating in an earlier study, which also held tumor genome data. Thus, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumor immune infiltrate, in particular with respect to the presence of cytotoxic T-lymphocytes (CD8) in the tumor, thus establishing a radiomic signature.

The researchers tested and validated this signature in other cohorts, including that of TCGA (The Cancer Genome Atlas), thus demonstrating that imaging could predict a biological phenomenon, providing an estimation of the degree of immune infiltration of a tumor. Further, in order to test the signature’s applicability in a real situation and correlate it to the efficacy of immunotherapy, it was evaluated using CT scans performed before the start of treatment in patients participating in five phase I trials of anti-PD-1/PD-L1 immunotherapy. The researchers found that the patients in whom immunotherapy was effective at three and six months had higher radiomic scores as did those with better overall survival.

In their next clinical study, the researchers will assess the signature both retrospectively and prospectively, using a larger number of patients and stratifying them based on cancer type in order to refine the signature. They will also use more sophisticated automatic learning and AI algorithms to predict patient response to immunotherapy, while integrating data from imaging, molecular biology and tissue analysis. The researchers aim to identify those patients who are most likely to respond to treatment, thereby improving the efficacy/cost ratio of treatment.



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

12 Nov 2018
ACR Data Science Institute Releases AI Use Cases to Accelerate AI Adoption
The American College of Radiology Data Science Institute has released a first-of-its-kind series of standardized artificial intelligence (AI) use cases that will accelerate medical imaging AI adoption. This continually updated, freely available use case series is the product of a previously missing and collaborative framework that enables efficient creation, implementation and ongoing improvement of radiological AI tools.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
12 Nov 2018
OpenSight Augmented Reality System for Microsoft HoloLens Cleared by FDA
The FDA has granted 510(k) clearance to the OpenSight Augmented Reality System, making it the first AR medical solution for Microsoft HoloLens to be cleared for use in pre-operative surgical planning. Developed by Novarad, a provider of specialized enterprise imaging and workflow solutions, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body.
Read More
12 Nov 2018
New AR Device Helps Cardiologists Plan and Perform Complex Procedures
Augmented Reality (AR), a technology that superimposes computer-generated information on a user's view of the real world, offers a new platform to help physicians better visualize complex medical data, particularly before and during medical procedures.
Read More
05 Nov 2018
Smart POC Tele-ultrasound Devices to Boost Demand in Global Market
The global point-of-care (POC) ultrasound systems market is projected to grow at a CAGR of nearly 9% during the period 2018-2022, driven mainly by awareness programs by organizations and vendors. A key trend in the global POC ultrasound systems market is the emergence of smart POC tele-ultrasound systems, which are expected to provide a boost to the demand in the market.
Read More
05 Nov 2018
Global Radiation Detection Market Driven by Healthcare Facility Demand
The global radiation detection and monitoring equipment market is projected to grow at a CAGR of nearly 6% during the period 2018-2022, driven by increasing demand from healthcare facilities due to the rising use of radiation-based equipment in the diagnosis and treatment of various health problems.
Read More
30 Oct 2018
ECG Imaging Algorithm Could Help Reduce Invasive Heart Procedures
A group of researchers from the University of California, Santa Barbara have developed new algorithms to localize the source of an atrial fibrillation, an abnormal heart rhythm.
Read More
30 Oct 2018
Philips Launches Start-Up AI Collaboration Program
Royal Philips has launched its first global start-up collaboration program involving the company’s innovation hubs in Cambridge, US, Eindhoven, the Netherlands, Bangalore, India and Shanghai, China focused on the application of artificial intelligence (AI) in healthcare. The program focuses on the application of AI-based clinical decision support tools, such as image interpretation, analysis and integration, and workflow tools, such as intelligent treatment plans for radiology, ultrasound and oncology.
Read More
25 Oct 2018
AI Could Help Radiologists Improve Osteoarthritis X-ray Diagnosis
Researchers from the Center for Digital Health Innovation at the University of California have developed a fully automated algorithm for the detection of osteoarthritis with radiographs using the 0–4 Kellgren Lawrence (KL) grading system with a state-of-the-art neural network.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions